2509 — Qyuns Therapeutics Co Balance Sheet
0.000.00%
Last trade - 00:00
- HK$4.06bn
- HK$4.04bn
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash | |||
Short Term Investments | |||
Cash and Short Term Investments | 620 | 614 | 377 |
Net Total Receivables | 8.65 | 4.04 | 10.6 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 648 | 636 | 418 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 406 | 389 | 363 |
Net Intangible Assets | |||
Long Term Notes Receivable | |||
Other Long Term Assets | |||
Total Assets | 1,067 | 1,035 | 796 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 69.7 | 122 | 252 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Deferred Income Tax | |||
Minority Interest | |||
Total Other Liabilities | |||
Total Liabilities | 397 | 393 | 501 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | 670 | 642 | 295 |
Total Liabilities & Shareholders' Equity | 1,067 | 1,035 | 796 |
Total Common Shares Outstanding |